---
schema_version: "secwatch.filing_event.v1"
accession: "0001964738-26-000045"
form_type: "8-K"
ticker: "SOLV"
cik: "0001964738"
company_name: "Solventum Corp"
filed_at: "2026-08-05T20:17:48+00:00"
generated_at: "2026-08-05T20:20:11.546500+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Solventum Q2 sales up 9.5% organic; adj. EPS $2.55 (+50.9%); plans to separate HIS segment

## Summary
- Sales $2.2B, organic +9.5%; GAAP EPS $0.53, adjusted EPS $2.55 (+50.9% YoY).
- Operating cash flow $227M, free cash flow $144M (+144% YoY).
- Announces intent to separate Health Information Systems business segment.
- Raises full-year 2026 guidance for organic sales growth, adjusted EPS, and free cash flow.
- CEO Bryan Hanson cites strong execution and transformation progress.

## SEC filing metadata
- accession: 0001964738-26-000045
- form_type: 8-K
- ticker: SOLV
- cik: 0001964738
- company_name: Solventum Corp
- filed_at: 2026-08-05T20:17:48+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/0001964738-26-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964738/000196473826000045/solv-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001964738-26-000045
- JSON: https://secwatch.observer/filing/0001964738-26-000045.json
- Plain text: https://secwatch.observer/filing/0001964738-26-000045.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.